Please provide your email address to receive an email when new articles are posted on . The meeting will take place June 21 in Las Vegas. Attendees will explore topics such as regulatory ...

Dublin, May 14, 2025 (GLOBE NEWSWIRE) -- The "Artificial Intelligence (AI) in Clinical Trials - Market Insights, Competitive Landscape, and Market Forecast - 2032" has been added to ...

The mixed results showed that ivonescimab plus chemotherapy reduced the risk of disease progression or death by 48% compared to chemotherapy alone. Summit Therapeutics announced its intention to file ...

New York, USA, May 07, 2025 (GLOBE NEWSWIRE) -- Global AI in Clinical Trials Market to Show Tremendous Growth at a CAGR of ~12% by 2032 | DelveInsight The demand for AI in clinical trials is ...

In this week’s edition of InnovationRx, we look at the impact of Trump’s proposed budget cuts on biomedical research and ...

Generative AI can support decisions about a clinical trial’s target patient population by enhancing subgroup discovery, refining trial eligibility criteria, and helping remove patients who are ...

Historically, large urban academic centres have conducted the majority of clinical trials, leading to such issues as ...

(MENAFN- GlobeNewsWire - Nasdaq) The AI in Clinical Trials Market is driven by the surge in chronic diseases and increased pharma collaborations. Valued at $1.35 billion in 2024, it aims to reach ...

In this issue: assessing the regulators' role as AI in clinical trials evolves, the potential for a newborn screening refresh ...

The integration of artificial intelligence (AI) and machine learning (ML) in oncology clinical trials is rapidly evolving alongside the broader field. For example, AI-driven adaptive trial designs may ...

As the largest funder of biomedical research in the world, the NIH is considered a global paragon. Budget cuts could lead to permanent cracks in the increasingly fragile research ecosystem, ...